A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

doi:10.1016/j.jfma.2019.04.007

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 生物科技系(所) > 期刊論文 > Item 310902800/34062

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34062

標題:	A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
作者:	Li, Yi-Heng Chen, Jaw-Wen Lin, Tsung-Hsien Wang, Yu-Chen Wu, Chau-Chung Yeh, Hung-, I Huang, Chin-Chou Chang, Kuan-Cheng Wu, Cho-Kai Chen, Po-Wei Huang, Chen-Wei Chen, Zhih-Cherng Chang, Wei-Ting Huang, Wei-Chun Wang, Chih-Yuan Lee, Mei-Yueh Chao, A-Ching Fu, Wei-Ren Tsai, Li-Kai Tang, Sung-Chun Chan, Hsin-Lung Yang, Yi-Ching Wu, Yen-Wen Hwang, Juey-Jen Lin, Jiunn-Lee
貢獻者:	Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Cardiol Natl Yang Ming Univ, Taipei Vet Gen Hosp & Inst Pharmacol, Dept Med Res & Educ Kaohsiung Med Univ, Kaohsiung Med Univ Hosp & Fac Med, Coll Med, Dept Internal Med,Div Cardiol China Med Univ, Asia Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med & Hosp Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Natl Taiwan Univ Hosp Natl Taiwan Univ, Grad Inst Med Educ & Bioeth, Coll Med Mackay Mem Hosp, Dept Internal Med & Med Res Mackay Med Coll, Dept Med Taipei Vet Gen Hosp, Dept Med Educ, Dept Med, Div Cardiol Natl Yang Ming Univ, Cardiovasc Res Ctr China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Cardiovasc Med China Med Univ, Coll Med Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med Natl Taiwan Univ, Coll Med Chi Mei Med Ctr, Dept Internal Med, Div Cardiol Chia Nan Univ Pharm & Sci, Dept Pharm Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Cardiol Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Fac Med Kaohsiung Med Univ Hosp, Dept Neurol Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med Kaohsiung Med Univ, Dept Neurol, Coll Med Mackay Mem Hosp, Dept Neurol Natl Taiwan Univ Hosp, Stroke Ctr & Dept Neurol Mackay Mem Hosp, Mackay Med Coll, Dept Family Med, Dept Med Natl Cheng Kung Univ, Dept Family Med, Natl Cheng Kung Univ Hosp, Coll Med ] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Cardiol Div Natl Yang Ming Univ, Sch Med Natl Taiwan Univ Hosp, Cardiol Div, Dept Internal Med Natl Taiwan Univ Hosp Yun Lin, Dept Internal Med, Div Cardiol Taipei Med Univ, Dept Internal Med, Div Cardiovasc Med, Shuang Ho Hosp
關鍵字:	Atherosclerosis Risk factors Performance guide
日期:	2020
上傳時間:	2022-11-18 11:22:19 (UTC+8)
出版者:	Elsevier Taiwan
摘要:	Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.
關聯:	Journal of The Formosan Medical Association, v.119, n.3, pp.11
顯示於類別:	[生物科技系(所)] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
10.1016j.jfma.2019.04.007.pdf		393Kb	Adobe PDF	144	檢視/開啟
index.html		0Kb	HTML	517	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....